Related Experiment Video
Updated: Aug 16, 2026

Biochemical Reconstitution of Steroid Receptor•Hsp90 Protein Complexes and Reactivation of Ligand Binding
Published on: September 21, 2011
Inactivation of hepatic glucocorticoid receptors by heparin
Abstract:
Heparin dramatically enhanced the rate of unbound glucocorticoid receptor inactivation in vitro in a concentration, time and temperature-dependent manner. Control specific binding decreased only about 25% after incubation for 6 h at 4 degrees C. However in the presence of heparin (40 micrograms per ml cytosol) receptor binding decreased about 75%. At 25 degrees C liver receptor specific binding was found to have a half-life of about 60 min in control cytosol. However, in the presence of heparin (40 micrograms per ml cytosol) the glucocorticoid receptor had a half-life of only 15 min at 25 degrees C. Interestingly, 10 mM molybdate (with or without 5 mM dithiothreitol) greatly inhibited heparin-dependent receptor inactivation at 4 degrees C. Dithiothreitol (alone) significantly stabilized receptor binding in control samples at 4 degrees C, but provided no protection from heparin-dependent receptor inactivation. Heparin had no apparent inactivating effect on prebound glucocorticoid receptor complexes at 4 degrees C. Interestingly however, heparin altered the sedimentation coefficient of prebound hepatic glucocorticoid-receptor complexes in low salt gradients from 7-8 S to about 3-4 S. When molybdate plus dithiothreitol were added with heparin, the sedimentation coefficient was found to be approx. 6-7 S. These results demonstrate that heparin, which is often used pharmacologically and which occurs naturally in animal tissues, has significant effects on liver glucocorticoid receptors in vitro.
Related Concept Videos
GPCR Desensitization
Drug Metabolism: Phase II Reactions
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Phase II Reactions: Glucuronidation
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

